ENTITY
SK Biopharmaceuticals

SK Biopharmaceuticals (326030 KS)

121
Analysis
Health CareSouth Korea
SK Biopharmaceuticals Co., Ltd. researches and develops new drugs. The Company develops and markets brain disorders treatment drugs, central nervous system disorders treatment drugs, and other products. SK Biopharmaceuticals markets its products worldwide.
more
Refresh
bearishDouzone Bizon
09 Sep 2020 08:34
Logo
476 Views
Share
bearishHYBE
08 Sep 2020 10:30

Interest Comparisons of Upcoming Korean Large-Cap IPOs: Kakao Games & Big Hit Entertainment

Based on the Smartkarma's platform interest rates comparison, there is overwhelming evidence that suggests the LACK of interest in the Big Hit...

Logo
271 Views
Share
bullishLG Chem Ltd
04 Sep 2020 12:20

Korea-New Deal Index: Constituents, Weights, & Market Reaction

The Korean government unveiled the specifics of the Korean version of the New Deal initiative.

Logo
321 Views
Share
10 Aug 2020 05:33

SK Biopharmaceuticals - KOSPI200 Inclusion Confirmed, Large Impact Expected

Late Friday evening, the KRX confirmed something that was widely expected. SK Biopharmaceuticals (326030 KS) meets the Fast Entry criteria for...

Logo
389 Views
Share
10 Aug 2020 01:07

Fast Entry of SK Biopharmaceuticals to KRX Indices, Incl. KOSPI 200

The KRX officially announced the fast entry of SK Biopharm to the following KRX indices in the form of Fast Entry. KOSPI 200 Fast-Entry If an IPO...

Logo
352 Views
Share
x